Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Orexigen Therapeutics, Inc. (NQ: OREX)
6.040 USD  -0.010 (-0.17%)
Official Closing Price  /  Updated: 4:00 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Orexigen Therapeutics, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
May 17, 2013
from PR Newswire
NASDAQ Decliners Watch List: Rockwell Medical, Inc. (NASDAQ:RMTI), VIVUS Inc. (NASDAQ:VVUS), and Orexigen Therapeutics, Inc. (NASDAQ:OREX) Added to Growing Stock Report's NASDAQ Decliners Watch List.
May 15, 2013
New York, NY -- (SBWIRE) -- 05/15/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Rockwell Medical, Inc. (NASDAQ:RMTI), VIVUS Inc. (NASDAQ:VVUS), and Orexigen... Read More
from SBWire - Latest Press Releases
Orexigen Therapeutics, Inc. (NASDAQ:OREX) Investor Alert: Investigation over Potential Wrongdoing
May 14, 2013
San Diego, CA -- (SBWIRE) -- 05/14/2013 -- An investigation on behalf of current long-term stockholders of shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX) was announced concerning whether certain... Read More
from SBWire - Latest Press Releases
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 13, 2013
from Business Wire News Releases
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
A cautious DEA meets a cautiously optimistic FDA Read More
category TOKYO:ESALY , NASDAQ:OREX , NASDAQ:ARNA , and 1 more.
from Forbes Real Time
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from PR Newswire
Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
May 08, 2013
from PR Newswire
Will The Prescription Diet Pill Market Finally Bulk Up?
May 08, 2013
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice of prescription diet pill options. First, Arena Pharmaceuticals disclosed... Read More
category NASDAQ:OREX , NASDAQ:ARNA , NASDAQ:VVUS
from Forbes Real Time
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.
May 07, 2013
from PR Newswire
MDT, HLF, OREX, and NVS Early Briefing and Review
May 06, 2013
from ACCESSWIRE
Company Update - Fri 3 May, 2013
May 03, 2013
Orex Amends Barsele Acquisition Agreement To Defer Cash Payment And Accelerate Share Payments Orex Minerals Inc. (“Orex” or the “Company”) – REX: TSX-V. Orex is pleased to announce that it has agreed... Read More
category Company Update , Orex
from Korelin Economics Report
VIVUS, Inc. (VVUS) Ticks Higher as Arena (ARNA) Pulls BELVIQ MAA in Europe
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8302843 for the full story. Read More
from StreetInsider.com News Articles
Arena Withdraws Application for Weight-Loss Drug Approval in Europe
May 03, 2013
DailyFinance.com : Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in... Read More
category orex , vvus , arna
from DailyFinance.com
Orexigen Therapeutics to Host First Quarter 2013 Financial Results Conference Call and Webcast
May 02, 2013
from PR Newswire
Market's Hot Equities Review & Reports For: (NYSE: RDN), (NASDAQ: OREX)
April 26, 2013
from SBWire Direct - Latest Press Releases
Equities Review and Reports For (NYSE: RDN) (NASDAQ: OREX)
April 26, 2013
from ACCESSWIRE
Orexigen Therapeutics Commends the Campaign to End Obesity's Report on Long-term Returns of Obesity Prevention Policies
April 25, 2013
from PR Newswire
Orexigen Therapeutics Has Returned 17.5% Since SmarTrend Recommendation (OREX)
April 25, 2013
from Comtex SmarTrend® News Briefs
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Orexigen Therapeutics, Inc. (NASDAQ:OREX), and Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 23, 2013
New York, NY -- (SBWIRE) -- 04/23/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Orexigen Therapeutics, Inc.... Read More
from SBWire - Latest Press Releases
Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
April 22, 2013
from PR Newswire
Stocks in News: ABIOMED, Dynavax Technologies, Orexigen Therapeutics, BioCryst Pharmaceuticals
April 18, 2013
Dallas, TX -- (SBWIRE) -- 04/18/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Orexigen Therapeutics Has Returned 15.7% Since SmarTrend Recommendation (OREX)
April 18, 2013
from Comtex SmarTrend® News Briefs
ABIOMED, Inc. (NASDAQ:ABMD), Orexigen Therapeutics, Inc. (NASDAQ:OREX), and Sinovac Biotech Ltd. (NASDAQ:SVA) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 17, 2013
New York, NY -- (SBWIRE) -- 04/17/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding ABIOMED, Inc. (NASDAQ:ABMD), Orexigen Therapeutics, Inc. (NASDAQ:OREX), and Sinovac... Read More
from SBWire - Latest Press Releases
Al's Insights - Wed 17 Apr, 2013
April 17, 2013
From the mining industry, Gary Cope finds this market to be non-sensical. Read More
category Al's Insights , Orex
from Korelin Economics Report
Stock Losers: Anheuser-Busch InBev NV, Illumina, Orexigen Therapeutics, Arch Coal Inc
April 11, 2013
Dallas, TX -- (SBWIRE) -- 04/11/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
NASDAQ Decliners Watch List: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Synageva BioPharma Corp. (NASDAQ:GEVA), and Hyperion Therapeutics, Inc. (NASDAQ:HPTX) Added to Growing Stock Report's NASDAQ Dec
April 04, 2013
New York, NY -- (SBWIRE) -- 04/04/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Orexigen Therapeutics, Inc. (NASDAQ:OREX), Synageva BioPharma Corp. (NASDAQ:GEVA),... Read More
from SBWire - Latest Press Releases
Morning Research on Teva Pharma, Orexigen Therapeutics, Zoetis, and Novartis
April 03, 2013
from PR Newswire
Stocks to Track: Foster Wheeler AG, LKQ Corporation, Orexigen Therapeutics, Crocs
April 01, 2013
Lakeway, TX -- (SBWIRE) -- 04/01/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Notable Gainers: MGIC Investment Corp.(NYSE:MTG) , ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Orexigen Therapeutics, Inc.(NASDAQ:OREX)
April 01, 2013
Lakeway, NY -- (SBWIRE) -- 04/01/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Stocks in Focus: Commercial Metals Company, UTi Worldwide Inc, Rentech, Orexigen Therapeutics
April 01, 2013
Lakeway, TX -- (SBWIRE) -- 04/01/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here